Atlas Trials

Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart

Clinical trial NCT01159353 · COMPLETED

Trial details

NCT number
NCT01159353
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2007-09-01
Primary completion
2008-04-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.